Report Detail

Request for Sample of this report

Pharma & Healthcare Global Hydroxycarbamide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4652594
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hydroxycarbamide market size was valued at US$ 267 million in 2024 and is forecast to a readjusted size of USD 386 million by 2031 with a CAGR of 5.5% during review period.
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
Global Hydroxycarbamide key players include Qilu Pharmaceutical, Beijing Jialin Pharma, Taj Pharma, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share nearly 60%, followed by Europe, and North America, both have a share about 40 percent.
In terms of product, Capsule is the largest segment, with a share over 60%. And in terms of application, the largest application is Sickle Cell Disease, followed by Cancer, etc.
This report is a detailed and comprehensive analysis for global Hydroxycarbamide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hydroxycarbamide market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Unit), 2020-2031
Global Hydroxycarbamide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Unit), 2020-2031
Global Hydroxycarbamide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Unit), 2020-2031
Global Hydroxycarbamide market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hydroxycarbamide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hydroxycarbamide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, Khandelwal Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hydroxycarbamide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsule
Tablet
Market segment by Application
Sickle Cell Disease
Cancer
Others
Major players covered
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hydroxycarbamide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hydroxycarbamide, with price, sales quantity, revenue, and global market share of Hydroxycarbamide from 2020 to 2025.
Chapter 3, the Hydroxycarbamide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hydroxycarbamide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hydroxycarbamide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hydroxycarbamide.
Chapter 14 and 15, to describe Hydroxycarbamide sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hydroxycarbamide Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Capsule
    • 1.3.3 Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hydroxycarbamide Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Sickle Cell Disease
    • 1.4.3 Cancer
    • 1.4.4 Others
  • 1.5 Global Hydroxycarbamide Market Size & Forecast
    • 1.5.1 Global Hydroxycarbamide Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hydroxycarbamide Sales Quantity (2020-2031)
    • 1.5.3 Global Hydroxycarbamide Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Bristol Myers Squibb
    • 2.1.1 Bristol Myers Squibb Details
    • 2.1.2 Bristol Myers Squibb Major Business
    • 2.1.3 Bristol Myers Squibb Hydroxycarbamide Product and Services
    • 2.1.4 Bristol Myers Squibb Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bristol Myers Squibb Recent Developments/Updates
  • 2.2 Taj Pharma
    • 2.2.1 Taj Pharma Details
    • 2.2.2 Taj Pharma Major Business
    • 2.2.3 Taj Pharma Hydroxycarbamide Product and Services
    • 2.2.4 Taj Pharma Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Taj Pharma Recent Developments/Updates
  • 2.3 Beijing Jialin Pharma
    • 2.3.1 Beijing Jialin Pharma Details
    • 2.3.2 Beijing Jialin Pharma Major Business
    • 2.3.3 Beijing Jialin Pharma Hydroxycarbamide Product and Services
    • 2.3.4 Beijing Jialin Pharma Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Beijing Jialin Pharma Recent Developments/Updates
  • 2.4 Qilu Pharmaceutical
    • 2.4.1 Qilu Pharmaceutical Details
    • 2.4.2 Qilu Pharmaceutical Major Business
    • 2.4.3 Qilu Pharmaceutical Hydroxycarbamide Product and Services
    • 2.4.4 Qilu Pharmaceutical Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.5 Teva Pharma
    • 2.5.1 Teva Pharma Details
    • 2.5.2 Teva Pharma Major Business
    • 2.5.3 Teva Pharma Hydroxycarbamide Product and Services
    • 2.5.4 Teva Pharma Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Teva Pharma Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Hydroxycarbamide Product and Services
    • 2.6.4 Cipla Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Zydus Cadila
    • 2.7.1 Zydus Cadila Details
    • 2.7.2 Zydus Cadila Major Business
    • 2.7.3 Zydus Cadila Hydroxycarbamide Product and Services
    • 2.7.4 Zydus Cadila Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Zydus Cadila Recent Developments/Updates
  • 2.8 United Biotech
    • 2.8.1 United Biotech Details
    • 2.8.2 United Biotech Major Business
    • 2.8.3 United Biotech Hydroxycarbamide Product and Services
    • 2.8.4 United Biotech Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 United Biotech Recent Developments/Updates
  • 2.9 Par Pharma
    • 2.9.1 Par Pharma Details
    • 2.9.2 Par Pharma Major Business
    • 2.9.3 Par Pharma Hydroxycarbamide Product and Services
    • 2.9.4 Par Pharma Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Par Pharma Recent Developments/Updates
  • 2.10 Khandelwal Laboratories
    • 2.10.1 Khandelwal Laboratories Details
    • 2.10.2 Khandelwal Laboratories Major Business
    • 2.10.3 Khandelwal Laboratories Hydroxycarbamide Product and Services
    • 2.10.4 Khandelwal Laboratories Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Khandelwal Laboratories Recent Developments/Updates
  • 2.11 Alkem (Cytomed)
    • 2.11.1 Alkem (Cytomed) Details
    • 2.11.2 Alkem (Cytomed) Major Business
    • 2.11.3 Alkem (Cytomed) Hydroxycarbamide Product and Services
    • 2.11.4 Alkem (Cytomed) Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Alkem (Cytomed) Recent Developments/Updates
  • 2.12 Samarth Pharma
    • 2.12.1 Samarth Pharma Details
    • 2.12.2 Samarth Pharma Major Business
    • 2.12.3 Samarth Pharma Hydroxycarbamide Product and Services
    • 2.12.4 Samarth Pharma Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Samarth Pharma Recent Developments/Updates
  • 2.13 VHB Life Sciences
    • 2.13.1 VHB Life Sciences Details
    • 2.13.2 VHB Life Sciences Major Business
    • 2.13.3 VHB Life Sciences Hydroxycarbamide Product and Services
    • 2.13.4 VHB Life Sciences Hydroxycarbamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 VHB Life Sciences Recent Developments/Updates

3 Competitive Environment: Hydroxycarbamide by Manufacturer

  • 3.1 Global Hydroxycarbamide Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hydroxycarbamide Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hydroxycarbamide Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hydroxycarbamide by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hydroxycarbamide Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hydroxycarbamide Manufacturer Market Share in 2024
  • 3.5 Hydroxycarbamide Market: Overall Company Footprint Analysis
    • 3.5.1 Hydroxycarbamide Market: Region Footprint
    • 3.5.2 Hydroxycarbamide Market: Company Product Type Footprint
    • 3.5.3 Hydroxycarbamide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hydroxycarbamide Market Size by Region
    • 4.1.1 Global Hydroxycarbamide Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hydroxycarbamide Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hydroxycarbamide Average Price by Region (2020-2031)
  • 4.2 North America Hydroxycarbamide Consumption Value (2020-2031)
  • 4.3 Europe Hydroxycarbamide Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hydroxycarbamide Consumption Value (2020-2031)
  • 4.5 South America Hydroxycarbamide Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hydroxycarbamide Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 5.2 Global Hydroxycarbamide Consumption Value by Type (2020-2031)
  • 5.3 Global Hydroxycarbamide Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 6.2 Global Hydroxycarbamide Consumption Value by Application (2020-2031)
  • 6.3 Global Hydroxycarbamide Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 7.2 North America Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 7.3 North America Hydroxycarbamide Market Size by Country
    • 7.3.1 North America Hydroxycarbamide Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hydroxycarbamide Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hydroxycarbamide Market Size by Country
    • 8.3.1 Europe Hydroxycarbamide Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hydroxycarbamide Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hydroxycarbamide Market Size by Region
    • 9.3.1 Asia-Pacific Hydroxycarbamide Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hydroxycarbamide Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 10.2 South America Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 10.3 South America Hydroxycarbamide Market Size by Country
    • 10.3.1 South America Hydroxycarbamide Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hydroxycarbamide Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hydroxycarbamide Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hydroxycarbamide Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hydroxycarbamide Market Size by Country
    • 11.3.1 Middle East & Africa Hydroxycarbamide Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hydroxycarbamide Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hydroxycarbamide Market Drivers
  • 12.2 Hydroxycarbamide Market Restraints
  • 12.3 Hydroxycarbamide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hydroxycarbamide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hydroxycarbamide
  • 13.3 Hydroxycarbamide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hydroxycarbamide Typical Distributors
  • 14.3 Hydroxycarbamide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hydroxycarbamide. Industry analysis & Market Report on Hydroxycarbamide is a syndicated market report, published as Global Hydroxycarbamide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Hydroxycarbamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo